SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-298155
Filing Date
2023-12-19
Accepted
2023-12-19 07:40:33
Documents
18
Period of Report
2023-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d669381d8k.htm   iXBRL 8-K 39346
2 EX-4.1 d669381dex41.htm EX-4.1 71046
3 EX-4.2 d669381dex42.htm EX-4.2 71047
4 EX-4.3 d669381dex43.htm EX-4.3 71047
5 EX-99.1 d669381dex991.htm EX-99.1 16598
10 GRAPHIC g669381g1219031149496.jpg GRAPHIC 6220
  Complete submission text file 0001193125-23-298155.txt   516584

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xoma-20231215.xsd EX-101.SCH 3870
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20231215_def.xml EX-101.DEF 14111
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20231215_lab.xml EX-101.LAB 23495
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20231215_pre.xml EX-101.PRE 15144
12 EXTRACTED XBRL INSTANCE DOCUMENT d669381d8k_htm.xml XML 6649
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 231495642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)